Integrating NACC UDSv3 into non AD/ADRD Cohorts: The Diabetes Prevention Program Outcomes Study in Alzheimer’s Diseases and Related Dementias (DPPOS)‐AD/ADRD Project Experience
Lindsay Doherty(George Washington University), James M. Noble(Harvard University), Gerardo Febres(Columbia University Irving Medical Center), Marinella Temprosa(Milken Institute), Neelesh K. Nadkarni(University of Pittsburgh), Danurys Sanchez(Columbia University Irving Medical Center), Terry E. Goldberg(Columbia University Irving Medical Center), Hanna Sherif(George Washington University), Anna Bowers(George Washington University), D. Barragán Martínez(New York State Department of State), José A. Luchsinger(Columbia University Irving Medical Center)
Cited by 0
Related Papers
Very Low Birth Weight Outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 Through December 1996
|PEDIATRICS|2001|1.5k
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
|Nature Medicine|2019|948
Executive Subprocesses in Working Memory
|Archives of General Psychiatry|2003|585
Association of Delirium With Long-term Cognitive Decline
|JAMA Neurology|2020|542
Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
|The Journal of Clinical Endocrinology & Metabolism|2016|518